Related Experiment Video
Updated: May 10, 2026

Hyperpolarized 13C Metabolic Magnetic Resonance Spectroscopy and Imaging
Published on: December 30, 2016
Estimating the Timeframe of Lactate Reduction in Acute Cardiovascular Disease Using Functional Data Analysis Based on
Takaya Nakashima1, Shuntaro Sato2, Hidetoshi Matsui3
1Department of Anesthesiology and Intensive Care Medicine, Nagasaki University Graduate School of Biomedical Sciences.
Reducing lactate levels is key for acute cardiovascular disease prognosis. This study found significant differences in lactate reduction timeframes across acute heart failure, aortic dissection, and ischemic heart disease patients.
Area of Science:
- Cardiology
- Intensive Care Medicine
- Biostatistics
Background:
- Lactate level monitoring is crucial for acute cardiovascular disease prognosis.
- Lactate reduction trends offer insights into patient condition evaluation.
- Specific cardiovascular diseases may exhibit distinct lactate clearance patterns.
Purpose of the Study:
- To estimate the timeframe of lactate reduction in patients with acute heart failure, aortic dissection, and ischemic heart disease.
- To analyze lactate level trends using functional data analysis and nonlinear mixed effects models.
- To provide data for developing tailored treatment plans based on disease-specific lactate reduction rates.
Main Methods:
- Functional data analysis with nonlinear mixed effects models was employed.
- Lactate trends were analyzed in 1,249 adult patients diagnosed with acute heart failure, aortic dissection, or ischemic heart disease.
- Data were collected from patients admitted to intensive care units between December 2010 and June 2020.
Main Results:
- Lactate reduction timeframes varied significantly by cardiovascular disease.
- Acute heart failure patients showed lactate reduction in 30 hours (95% CI, 23-37 hours).
- Aortic dissection patients required 40 hours (95% CI, 33-47 hours) for lactate reduction.
- Ischemic heart disease patients exhibited the longest lactate reduction timeframe at 95 hours (95% CI, 49-failed estimate).
Conclusions:
- The study successfully estimated disease-specific lactate reduction timeframes in cardiovascular patients.
- Recognizing these differences can inform the development of personalized treatment strategies.
- Understanding lactate kinetics is vital for optimizing patient outcomes in critical cardiovascular conditions.
More Related Videos
Related Concept Videos
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This relationship...
Pharmacodynamic Models: Linear Concentration–Effect Model
Pharmacodynamic Models: Logarithmic Concentration–Effect Model

